72. 12. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. Journal Gastroenterology. 2007; 42(1):1-15.
73. Annibale B, Marignani M, Monarca B, Antonelli G, Marcheggiano A, Martino G, et al. Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis. Ann International Medical. 2007;131: 668-672.
74. Diez EM, Torres GE, Layrisse M, Leets I, Vizcaino G, Arteaga VM. Prevalence of anemia, iron, folic acid and vitamin B12 deficiency in two Bari Indian communities from western Venezuela. Investigation Clinic. 2005;38: 191-201.
75. Jonsson V, Kierkegaard A, Salling S, Molander S, Andersen LP, Christiansen M, et al. Autoimmunity in Waldenstrom's macroglobulinaemia. Leuk Lymphom 2006;34: 373-379.
76. Bahmanyar S, Zendehdel K, Nyrén O, Ye W. Risk of oesophageal cancer by histology among patients hospitalized for gastroduodenal ulcers. Gut. 2007; 56(4):464-8.
77. Love JW. Peptic ulceration may be a hormonal deficiency disease. Medical Hypotheses. 2008; 70(6):1103-1107.
78. Montes TP, Salazar VS, Monge SE. Epidemiological changes in peptic ulcer and their relation with Helicobacter pylori. Hospital Daniel A Carrion 2000-2005. Revist Gastroenterology Peru. 2007; 27(4):382-388.
79. Mavromichalis I, Zaramboukas T, Giala MM. Migraine of gastrointestinal origin. European Journal Pediatry 2007;154: 406-410.
80. Martide AC, Boixeda D, Fuertes A, Canton R, Barba M, Gispert JP, et al. Helicobacter pylori infection and coronary heart disease. Gut 2005; 37(Suppl 1):25-29.
81. Folsom AR, Nieto FJ, Sorlie P, Chambless LE, Graham DY. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. Circulation 2005;98: 845-850.
82. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men [see comments]. Heart 2007; 75:568-572.
83. Niemela S, Karttunen T, Korhonen T, Laara E, Karttunen R, Ikaheimo M, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 2008;75: 573-575.
84. Sung JJY, Sanderson JE. Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart 2006;76:305-7.
85. Omar EM. The importance of interleukin-1beta in Helicobacter pylori associated disease. Gut 2001;48:743-747.
86. Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut. 2007; 56(7):918-25.
87. Stamler JS, Osborne JA, Jaraki M, Rabbini LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. Journal Clinical Investigation 2007;91:308-318.
88. Stampfer MJ, Malinow MR, Wiler WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocysteine and risk of miocardial infarction in US physicians. JAMA 2006;268: 877-881.
89. Raymond J, Bergeret M, Benhamou PH, Mensah K, Dupont C. A two-year of H. pylori infection in children. Journal Clinical Microbiology. 2007;32: 461-463.
90. Brieva L, Ara JR, Bertol V, Canellas A, Agua C del. Polyneuropathy caused by vitamin B12 deficiency secondary to chronic atrophic gastritis and giardiasis. Revist Neurology 2006;26: 1019-1020.
91. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 2005; 142; 207-210.
92. Muhlestein JB. Bacterial infections and atherosclerosis. Journal Investigation Medical 2007;46: 396-402.
93. Das UN. Hypothesis: cis-unsaturated fatty acids as potential anti-peptic ulcer drugs. Prostaglandins Leukot Essent Fatty Acids. Journal Investigation Medical 2006;58:377-380.
94. Birnie DH, Holme ER, McKay IC, Hood S, McColl KE, Hillis WS. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. European Heart Journal 2007;19:387-394.
95. Vaira D, Holton J, Menegatti M, et al. Review article: invasive and noninvasive tests for Helicobacter pylori infection. Alimentary. Pharmacology and Therapeutics. 2007;14(suppl 3):13–22.
96. McManus TJ. Helicobacter pylori: an emerging infectious disease. Nurse Practitioner. 2006;25(8):42–46.
97. Sheu BS, Yang HB, Wang YL, Chuang CH, Huang AH, Wu JJ. Pretreatment gastric histology is helpful to predict the symptomatic response after Helicobacter pylori eradication in patient with non ulcer dyspepsia. Dig Dis Scientifc 2008; 46 : 2700-2707.
Autores
Dra. Ismary Delgado Abreu (1)
Dra. Islaidy Delgado Abreu (2), Dra. Teresa Abreu Peña (3),
Dra. Teresa Haza Medina (4),
Dr. Félix Manuel Ponce Rodríguez (5).
1) Especialista en I Grado en Medicina General Integral y en Gastroenterología. Policlínica "Celia Sánchez Manduley". Ciénaga de Zapata.
2) Especialista de I Grado en Medicina General Integral y en Psiquiatría. Profesora Instructora. Policlínica "Celia Sánchez Manduley". Ciénaga de Zapata. 3) Especialista de I Grado en Medicina General Integral. Profesora Instructora. Policlínica "Wilfredo Díaz". Jagüey Grande.
4) Especialista de 2do Grado en Gastroenterología. Profesora Auxiliar. Hospital Clínico-Quirúrgico Provincial Cdte. "Faustino Pérez Hernández" Matanzas.
5) Especialista de 1er Grado en Gastroenterología. Profesor Asistente. Master en enfermedades infecciosas. Hospital Clínico-Quirúrgico Provincial Cdte. "Faustino Pérez Hernández" Matanzas.
POLICLÍNICA DOCENTE "CELIA SÁNCHEZ MANDULEY". CIÉNAGA DE ZAPATA.
Revista Médica Electrónica.
| Página siguiente |